Breaking

Post Top Ad

Your Ad Spot

Wednesday, May 2, 2018

FDA Approves Space Age Drug That Reprograms Cancerous Blood Cells


The FDA just approved a cutting-edge therapy to treat more patients with certain forms of blood cancer. Kymriah received its second approval to treat certain forms of leukemia and lymphoma. The therapy works by taking a person's own cells, reprogramming them, and inserting them back into the body to fight the cancer — in this case, certain forms of blood cancer. Dr. Tim Cripe is an oncologist who was part of the FDA advisory committee panel that voted in July to recommend the drug's initial approval. He said he thinks this is "the most exciting thing" he's seen in his lifetime." Made by Novartis, the personalized, high-tech, one-off drug has a hefty price tag of $475,000. https://ift.tt/2KtpORr http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com

No comments:

Post a Comment

Post Top Ad

Your Ad Spot

Pages